GHS Webinar Series
The Globally Harmonized System of Classification and Labeling Chemicals (GHS) is a hazard identification (classification) and communication (labeling) framework that is currently being implemented around the world. In the US, companies are required to have a GHS-compliant classification and labeling scheme in place by June 1, 2015. Although a key objective of the GHS is to "harmonize" hazard communication it is not a regulation in itself, and countries have modified and implemented GHS principles differently. Furthermore, several elements of the GHS framework are subject to scientific interpretation. It is not uncommon for a chemical to be classified differently across companies and within a company across countries. This poses several business considerations, including the resources needed for the consistent communication of hazards to workers and consumers, as well as protecting confidential business information. This changing landscape of chemical assessment also requires a re-examination of liabilities related to regulatory enforcement, potential litigation, and commercial harm that may result from inadequate assessment practices.
Despite these challenges, GHS implementation offers unique opportunities for companies to build a comprehensive understanding of their chemical and product portfolio. This can be leveraged into a robust product stewardship program that integrates GHS activities with emerging market demands for "sustainable" products. Several organizations have recognized this and developed "green" classification and labeling systems that are based largely on GHS principles. Overall, this webinar series is intended to explore the scientific, legal, and business implications brought on by the widespread implementation of GHS principles. Attendees will learn about (1) the basics of hazard classification in accordance with GHS; (2) technical, business, and legal challenges associated with GHS implementation and how to address them; and (3) new business prospects GHS implementation may provide.
Module 1 will provide a brief introduction to the GHS, how it is being implemented across various countries and jurisdictions, and what businesses should be doing to prepare for implementation. Through various "mock" examples, we will illustrate how scientists may use the same data to arrive at different hazard conclusions. We will discuss the legal and ethical responsibility of marketers throughout the supply chain to verify hazard conclusions and how a company's risk philosophy may influence final hazard determinations for compounds with ambiguous or conflicting data. This module will also address the legal implications of GHS as it relates to regulatory enforcement and product liability.
Bergeson & Campbell PC
Bergeson & Campbell PC
In addition to being the basis for regulatory compliance, GHS underlies many "green chemistry" ranking, certification, and labeling systems. Module 2 will provide an overview of existing GHS-based "green" evaluation tools and illustrate how GHS compliance obligations can be turned into a proactive product stewardship program that aligns with green chemistry principles. We will also explore the role of GHS-based hazard assessment in emerging "green chemistry" regulatory initiatives.
Gradient is an environmental and risk science consulting firm renowned for our specialties in Toxicology, Epidemiology, Risk Assessment, Product Safety, Contaminant Fate and Transport, and Environmental Chemistry. We employ sound science to assist national and global clients in resolving their complex problems relating to chemicals in the environment, in the workplace, and in consumer products.
Bergeson & Campbell, P.C. (B&C®) is a Washington D.C. law firm focusing on conventional, biobased, and nanoscale industrial, agricultural, and specialty chemical product regulation and approval matters, including Toxic Substances Control Act (TSCA) matters, Federal Insecticide, Fungicide and Rodenticide Act (FIFRA)/Food Quality Protection Act (FQPA) matters, U.S. Food and Drug Administration (FDA) medical device and product approval, registration and data compensation arbitrations, chemical product litigation, and associated business counseling and litigation issues.